Selective Rac-1 inhibition protects from diabetes-induced vascular injury

Carmine Vecchione1, Alessandra Aretini, Gennaro Marino

  • 1Department of AngioCardioNeurology, IRCCS NEUROMED, Località Camerelle, 86077 Pozzilli, Italy.

Circulation Research
|December 17, 2005
PubMed

Insights

Diabetes mellitus causes vascular damage through oxidative stress and Rac-1 activation. Inhibiting Rac-1 protects against this diabetes-induced vascular injury, offering a potential therapeutic target.

Area of Science:

  • Cardiovascular Biology
  • Metabolic Diseases
  • Molecular Medicine

Background:

  • Diabetes mellitus is a primary risk factor for vascular diseases.
  • Diabetic vasculopathy involves endothelial dysfunction driven by oxidative stress.
  • The precise molecular pathways of diabetes-induced vascular damage are not fully understood.

Purpose of the Study:

  • To investigate the role of oxidative stress and Rac-1 activation in diabetes-induced vascular injury.
  • To determine if Rac-1 is a key mediator in the vasculotoxic effects of diabetes.

Main Methods:

  • Utilized murine models of diabetes mellitus and high glucose-treated endothelial cells.
  • Assessed oxidative stress markers and Rac-1 activity (including Rac-1/PAK binding and translocation).
  • Employed adenoviral vector-mediated dominant-negative Rac-1 inhibition to assess protective effects.

Main Results:

  • Diabetes and high glucose significantly increased oxidative stress and Rac-1 activity in vascular tissues and endothelial cells.
  • Enhanced Rac-1 activity was evidenced by increased Rac-1/PAK binding and translocation to the plasma membrane.
  • Selective inhibition of Rac-1 using a dominant-negative mutant conferred protection against oxidative stress and vascular dysfunction.

Conclusions:

  • Rac-1 plays a critical role in mediating vascular injury associated with diabetes mellitus.
  • Targeting Rac-1 presents a promising therapeutic strategy for mitigating vascular complications in diabetic patients.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...